142 related articles for article (PubMed ID: 32531723)
41. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
[TBL] [Abstract][Full Text] [Related]
42. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
Testo N; Olson LC; Subramaniyam S; Hanson T; Magro CM
Am J Dermatopathol; 2016 Oct; 38(10):769-74. PubMed ID: 27391453
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
[TBL] [Abstract][Full Text] [Related]
44. Burkitt-like lymphoma with 11q aberration confirmed by needle biopsy of the liver: A case report.
Yang HJ; Wang ZM
World J Clin Cases; 2022 Sep; 10(26):9470-9477. PubMed ID: 36159440
[TBL] [Abstract][Full Text] [Related]
45. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
Gebauer N; Bernard V; Feller AC; Merz H
Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
[TBL] [Abstract][Full Text] [Related]
46. Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.
Boensch M; Oberthuer A; Fischer M; Skowron M; Oestreich J; Berthold F; Spitz R
Diagn Mol Pathol; 2005 Sep; 14(3):177-82. PubMed ID: 16106200
[TBL] [Abstract][Full Text] [Related]
47. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
48. Burkitt-like lymphoma with 11q aberrations: a highly apoptotic and high-grade lymphoma.
Yu YT; Chang KC
Blood; 2022 Feb; 139(5):797. PubMed ID: 35113146
[No Abstract] [Full Text] [Related]
49. Distinct genetic alterations in Burkitt-like lymphoma with 11q aberration and Burkitt lymphoma: a novel case report of composite lymphoma.
Kim M; Hwang HS; Yoon DH; Chun SM; Go H
Haematologica; 2022 Aug; 107(8):1999-2003. PubMed ID: 35354255
[No Abstract] [Full Text] [Related]
50. Burkitt Lymphoma and Other High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 Rearrangements.
Alsharif R; Dunleavy K
Hematol Oncol Clin North Am; 2019 Aug; 33(4):587-596. PubMed ID: 31229156
[TBL] [Abstract][Full Text] [Related]
51. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
Ruzinova MB; Caron T; Rodig SJ
Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
[TBL] [Abstract][Full Text] [Related]
52. Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis.
Lynnhtun K; Renthawa J; Varikatt W
Pathology; 2014 Apr; 46(3):211-5. PubMed ID: 24614699
[TBL] [Abstract][Full Text] [Related]
53. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
[TBL] [Abstract][Full Text] [Related]
54. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
Boerma EG; Siebert R; Kluin PM; Baudis M
Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
[TBL] [Abstract][Full Text] [Related]
55. Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.
Chisholm KM; Bangs CD; Bacchi CE; Molina-Kirsch H; Cherry A; Natkunam Y
Am J Surg Pathol; 2015 Mar; 39(3):294-303. PubMed ID: 25581730
[TBL] [Abstract][Full Text] [Related]
56. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
[TBL] [Abstract][Full Text] [Related]
57. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
58. Molecular and Cytogenetic Studies in a Child with Burkitt Lymphoma and Ataxia-Telangiectasia Syndrome Harboring MYC Overexpression and Partial Trisomy 8.
De Souza MT; Vera-Lozada G; Othman M; Marques-Salles TJ; Pinto LW; da Rocha MM; Rouxinol S; Liehr T; Ribeiro RC; Hassan R; Silva MLM
Ann Lab Med; 2018 Jan; 38(1):63-66. PubMed ID: 29071822
[No Abstract] [Full Text] [Related]
59. A very Burkitt-like case of Burkitt-like lymphoma with 11q aberration.
Aypar U; Ewalt MD
Blood; 2022 Mar; 139(11):1771. PubMed ID: 35298595
[No Abstract] [Full Text] [Related]
60. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]